CARIS LIFE SCIENCES INC (CAI)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$25.07-0.99%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CAI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | 989.6 | 812.0 | 412.3 | 306.1 | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 117.1 | 101.6 | 113.9 | 116.9 | — |
| Operating Income | 153.3 | 45.1 | (257.1) | (319.6) | — |
| Earnings from Continuing Operations | |||||
| Interest Expense | — | 56.9 | — | — | — |
| Other Non-Operating Income / Expenses | (48.2) | (113.2) | (24.8) | (21.9) | — |
| EBT, Incl. Unusual Items | 105.0 | (68.1) | (281.9) | (341.4) | — |
| Income Tax Expense | — | — | 0.0 | 0.0 | — |
| Net Income | |||||
| Net Income | 105.1 | (68.1) | (281.9) | (341.4) | — |
| Per Share | |||||
| Basic EPS | 0.37 | (3.22) | (10.66) | (13.24) | — |
| Diluted EPS | 0.37 | (3.22) | (10.66) | (13.24) | — |
| Revenue per Share | 3.50 | — | — | — | — |
| Basic Weighted Avg Shares | 282.9 | 167.2 | 35.5 | 34.9 | — |
| Diluted Weighted Avg Shares | 282.9 | 167.2 | 35.5 | 34.9 | — |
| Supplemental | |||||
| EBITDA | — | 67.7 | (208.2) | (270.6) | — |
| EBIT | 153.3 | 45.1 | (257.1) | (319.6) | — |
| Effective Tax Rate | — | — | 0.0% | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.